Kuros Biosciences AG (KURN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CHF
| Market Cap | 1.06B |
| Enterprise Value | 1.04B |
| P/E Ratio | 108.84 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 5.65 |
| Price/Book Ratio | 10.8 |
| Enterprise/Revenue | 5.67 |
| Enterprise/EBITDA | 68.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.05 |
| Operating Margin | 0.06 |
| Return On Assets | 0.06 |
| Return On Equity | 0.1 |
| Revenue | 121.3M |
| Revenue/Share | 3.52 |
| Gross Profit | 104.79M |
| EBITDA | 10.01M |
| Net Income | 2.12M |
| Diluted EPS | 0.05 |
| Total Cash | 7.85M |
| Total Cash/Share | 0.2 |
| Total Debt | 11.01M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.87 |
| Book Value Per Share | 1.82 |
| 52-Week Change | -27.84 |
| 52-Week High | 32.48 |
| 52-Week Low | 16.46 |
| Moving Average 50 Days | 18.71 |
| Moving Average 200 Days | 21.41 |
| Average Volume | 230,466 |
| Shares Outstanding | 39.76M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 08, 2020 |